Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks

Autor:	Matthias Peipp, Martin Gramatzki, Jan Brdon, Anna Otte, Renate Burger
Rok vydání:	2021
Předmět:	Ruxolitinib Text mining biology business.industry biology.protein medicine Cancer research Hematology Interleukin 6 business Intracellular medicine.drug
Zdroj:	Haematologica. 106:2507-2510
ISSN:	1592-8721 0390-6078
DOI:	10.3324/haematol.2020.276865
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d4e5d165701ba7d56be538f8b3ff802b https://doi.org/10.3324/haematol.2020.276865 Zobrazit plný text záznamu